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Supplementary Figure 2. The percentage of sequences containing the autoreactive “NHS and 
“AVY” motifs between COVID patients with improving, stable or worsening symptoms. IGHG1 (red 
box) was the only significant correlation. P-values are determined by MANOVA. 
  
  Supplementary Material 
 4 
 
Supplementary Figure 3. Distribution of sequences with different numbers of mutations from 




Supplementary Figure 4. Analysis of batch effects between the three sequencing runs. To normalise 
for different sequence numbers for each sample, a random subsample of 10,000 sequences per 
sample was taken. The clonotype convergence between each sample was then calculated using the 
jaccard index. Samples are hierarchically clustered in the heatmap based on this jaccard index. 
  




Supplementary Figure 5. Properties of the 1,254 convergent clonotypes (A) Isotype subclass usage 








Supplementary Figure 6. Lineage trees of the convergent clonotype that matched to the 
bronchoalveolar lavage fluid data. Each lineage tree represents the members of the clonotype from 
each of the ten patients it was present in. Each node represents a unique sequence within the 
clonotype lineage tree, with the size indicative of the number of duplicate sequences present. 
Numbers on the edges of adjoining nodes show the number of mutations between the sequences. 
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Supplementary Table 1. Summary of number of unique sequences, and number of clonotypes 
obtained for each COVID-19 patient. 
 
Participant ID Gender Age Status Unique BCR Sequences Clonotypes 
1 Female 48 Improving 184,613 30,438 
2 Male 44 Stable 287,865 60,806 
3 Male 66 Improving 169,645 21,928 
4 Male 71 Improving 210,148 24,243 
5 Male 86 Stable 235,013 34,368 
6 Female 63 Stable 122,610 13,366 
7 Female 82 Improving 217,356 21,004 
8 Female 69 Stable 123,741 16,296 
9 Female 57 Improving 194,778 20,779 
10 Male 69 Stable 202,162 17,103 
11 Male 69 Improving 152,272 17,144 
12 Male 65 Improving 121,320 12,089 
13 Female 33 Deteriorating 47,901 15,556 
14 Male 40 Stable 257,725 53,649 
15 Male 55 Stable 33,124 9,668 
16 Male 78 Stable 37,168 10,828 
17 Female 70 Stable 198,822 20,332 
18 Male 39 Improving 233,408 26,604 
19 Male 36 Improving 51,346 22,354 
20 Male 52 Stable 39,325 9,475 
21 Male 76 Deteriorating 221,975 18,588 
22 Female 71 Stable 54,684 9,327 
23 Male 26 Stable 202,995 41,493 
24 Female 87 Stable 31,049 6,842 
25 Male 29 Stable 41,025 14,840 
26 Male 49 Stable 171,278 21,689 
27 Male 35 Stable 280,496 36,937 
28 Female 59 Stable 29,641 8,797 
29 Female 42 Stable 253,163 35,211 
30 Male 37 Improving 60,364 15,180 
31 Male 40 Improving 329,223 78,400 




Supplementary Table 2. Summary of number of unique sequences, and number of clonotypes 
obtained for each healthy control subject. Only IGHA and IGHG data are included. 
 
Participant ID Gender Age Unique BCR Sequences Clonotypes 
Co_C.001.2_PB Male 39 7,820 4,426 
Co_C.002.1_PB Male 35 43,813 12,481 
Co_C.003.1_PB Male 26 5,981 4,148 
Co_C.004.1_PB Female 27 10,098 5,203 
Co_C.005.1_PB Female 26 27,345 9,238 
Co_C.012.1_PB Female 26 17,204 12,198 
Co_C.013.1_PB Female 24 9,201 5,080 
Co_C.016.3_PB Female 25 8,792 3,991 
Co_C.017.2_PB Male 41 13,720 7,293 
Co_C.018.1_PB Male 33 6,079 4,268 
Co_C.020.1_PB Female 28 8,127 2,540 
Co_C.025.1_PB Male 30 56,489 18,265 
Co_C.026.1_PB Female 29 40,625 18,091 
Co_C.033.2_PB Female 15 21,652 5,194 
Co_C.038.1_PB Female 26 46,079 17,419 
Co_C.040.1_PB Male 20 140,640 27,263 
Co_C.042.1_PB Female 31 85,509 18,822 
Co_C.045.1_PB Female 51 35,540 8,038 
Co_C.046.1_PB Female 11 70,534 24,515 
Co_C.047.1_PB Female 18 148,395 20,784 
Co_C.048.1_PB Female 45 65,230 13,277 
Co_C.049.1_PB Female 25 97,538 23,486 
Co_C.051.1_PB Male 22 1,376 1,074 
Co_C.052.1_PB Male 15 9,466 4,126 
Co_C.055.1_PB Male 43 8,061 3,894 
Co_C.056.1_PB Female 30 9,048 4,659 
Co_C.060.1_PB Male 31 34,139 10,322 
Co_C.061.1_PB Male 36 12,578 6,016 
Co_C.062.1_PB Female 14 1,709 1,134 
Co_C.063.1_PB Male 20 15,348 6,424 
Co_C.065.1_PB Female 23 37,262 9,525 
Co_C.076.1_PB Female 34 7,068 2,792 
Co_C.077.1_PB Female 26 18,637 3,726 
Co_C.078.1_PB Female 26 15,383 3,505 
Co_P.166.1_PB Female 36 40,549 7,489 
Co_P.170.1_PB Female 45 41,564 14,183 
Co_P.178.1_PB Female 34 13,803 3,767 
Co_P.190.1_PB Female 11 4,565 2,245 
Co_P.191.1_PB Male 18 5,789 2,705 
Co_P.197.1_PB Female 15 99,308 19,654 
Total: 1,342,064 373,260 
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Supplementary Table 3. CDRH3 AA sequences identified from bronchoalveolar RNAseq data. 
Highlighted in green is the one identified in our SARS-CoV-2 patient dataset. 
 
bestVHit bestJHit aaSeqCDR3 
IGHV2-26 IGHJ3 CARDSGRHLGPFDIW 
IGHV1-2 IGHJ3 CATPYYYDGGLDAFDIW 
IGHV3-74 IGHJ5 CARDLSRTNWFDPW 
IGHV3-15 IGHJ4 CTTDLHDYGDSDYW 
IGHV3-15 IGHJ4 CTTDFGGMITFGGVLRRI 
IGHV3-21 IGHJ4 CARAQSRGGYDSFFDFW 
IGHV3-21 IGHJ4 CGRGGPGTGIDYW 
IGHV4-59 IGHJ5 CARGGQYNNWFAPW 
IGHV3-74 IGHJ5 CVRDLSRTNWFDPW 
IGHV3-15 IGHJ4 YTRDLHDYGDSDYW 
IGHV3-23 IGHJ3 CAKIPSFLSDYDVHPNDAIDIW 
IGHV5-10-1 IGHJ4 CARHPQGAQFSNLGTYYFDYW 
IGHV4-59 IGHJ4 CARDGEYGGLAMW 
IGHV5-51 IGHJ6 CARPGTYYDILTGYSNHGMDVW 
IGHV4-39 IGHJ5 CARHASFRGTNYNWFDPW 




Supplementary Table 4. Convergent clonotypes with high CDRH3 homology to antibodies in the 
CoV-AbDab. Name: ID of the sequence. Black text represents the convergent clonotypes from this 
study, and blue text represent antibodies from CoV-AbDab. Highlighted in yellow are those which 
would be considered to belong to the same clonotype and are represented in Table 1. CDRH3: 
CDRH3 amino acid sequence. Green residues represent sequence matches between the convergent 
clonotype and the CoV-AbDab sequence, and red residues represent mismatches. IGHV: IGHV gene 
segment of the sequence. Green text represents matches between the convergent clonotype and the 
CoV-AbDab query sequence, and red text represents mismatches. IGHJ: IGHJ gene segment of the 
sequence. Green text represents matches between the convergent clonotype and the CoV-AbDab 
query sequence, and red text represents mismatches. ND – not determined. Binds/Neutralises: 
Experimental confirmation of whether the sequence binds SARS-CoV-1 or SARS-CoV-2. 
 
Name CDRH3 IGHV IGHJ Binds Neutralises Reference 
C154 AKQ-AGPYCSGGSCYSAPFDY 3-30 4 CoV-1, CoV-2 CoV-2 Robbiani et al., 2020  
ALC_3983948 AKV-SGPYCSGGSCYSFYFDY 3-30 4      
ALC_4259294 AKMGGGPYCSGGSCYSNYFDY 3-30 4       
COV2-2901 ARSYDILTGYRDAFDI 3-53 3 CoV-2   
Zost et al., 2020  COV2-2068 
ARSYDILTGYRDAFDI 3-53 3 CoV-2 CoV-2 
COV2-2767 ARSYDILTGYRDAFDI 3-53 3 CoV-2   
COV2-2790 ARSYDILTGYRDAFDI 3-53 3 CoV-2 CoV-2 
ALC_2318471 VRNYDILTGYSDAFDI 3-53 3       
COV2-2007 AKVSATYYYYYYGMDV 3-30 6 CoV-1, CoV-2   Zost et al., 2020  
CC12.17 AKSSGSYYYYYYGMDV 3-30 6 CoV-2 CoV-2 Rogers et al., 2020  
ALC_2318830 AKVMTTYYYYYYGMDV 3-30 6       
REGN10977 ARTPFYYDSSGYYLDY 1-69 4 CoV-2 CoV-2 Hansen et al., 2020  
COVA2-14 ARVR-YYDSSGYYEDY 1-69 4 CoV-1, CoV-2   Brouwer et al., 2020  
ALC_1780442 ARYD-YYDSSGYYLDY 1-69 4       
COV2-2270 AITYYYDSSGYWWDD 1-69 4 CoV-1, CoV-2   Zost et al., 2020  
ALC_1781971 ASTYYYDSSGYWFDY 1-69 4       
COVA2-40 AGRYCSGGRCGWFDP 4-4 5 CoV-2   Brouwer et al., 2020  
ALC_1784026 ESRYCSGGSCGWFDP 4-4 5       
COV2-2147 ARSTSGSYYYGMDV 3-30-3 6 CoV-1, CoV-2   Zost et al., 2020  
COV2-2341 ARSTSGSYYYGMDV 3-30-3 6 CoV-1, CoV-2   
COV2-2160 ARSTSGSYYYGMDV 3-30-3 6 CoV-1, CoV-2   
COV2-2159 ARSTSGSYYYGMDV 3-30-3 6 CoV-1, CoV-2   
CV27 ARSFGGSYYYGMDV 3-30 6 CoV-2   Seydoux et al., 2020  
CV34 ARSYGGSYYYGMDV 3-30-3 6 CoV-2   
ALC_1248726 ARAYSGSYYYGMDV 3-53 6      
ALC_1249094 ARGTRGSYYYGMDV 3-30-3 6      
ALC_1255857 ARGFGGSYYYGMDV 3-53 6      
ALC_1251900 ARAYSGSYYYGMDV 3-7 6       
COV2-2639 ARAGGGSYRGPFDY 3-30 4 CoV-1, CoV-2   Zost et al., 2020  
2M-14E5 ARSGGGSYRGPFDY 3-30 4 CoV-2   
ALC_1245591 ARVIGGSYRGPFDY 3-30-3 4       
COV2-2006 ARPQSGGYYAPLDY 3-30-3 4 CoV-1, CoV-2   Zost et al., 2020  
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ALC_1246650 ARPYSGSYYAPLDY 3-30-3 4       
S304 ARGDSSGYYYYFDY 3-13 4 CoV-1, CoV-2 CoV-1, CoV-2 Pinto et al., 2020  
ALC_1245048 ARGYSSGYYYYFDY 3-13 4       
COV2-2027 AIYGYYYYGLDV 3-30 6 CoV-2   Zost et al., 2020  
ALC_480504 AVYGYYYYGMDV 3-30 6      
ALC_481016 ASYGYYYYGMDV 3-30-3 6       
COVA2-04 ARDLERAGGMDV 3-53 6 CoV-2 CoV-2 Brouwer et al., 2020  
ALC_498298 ARDLEAAGGMDV 3-66 6       
CA1 AREGYCSGGSCYSGYYYYYGMDV 1-18 6 CoV-2 CoV-2 Shi et al., 2020  
ALC_4634307 AREGYCSGGSCYTDYYYYYGMDV 3-7 6      
ALC_4258298 ARDTYCSGGSCY--YYYYYGMDV 3-7 6      
COV2-2445 ARRRSSSRYSSGWYMYYYYMDV 3-33 6 CoV-2   
Zost et al., 2020  COV2-2173 ARRRSSSRYSSGWYMYYYYMDV 3-20 6 CoV-2   
COV2-2191 ARRRSSSRYSSGWYMYYYYMDV 3-20 6 CoV-2   
ALC_4259233 ARDVSSSWYSSGWY-YYYYMDV 3-7 6       
COVA1-19 ARWKS-DYYDSSGYYPAAFDI 3-21 3 CoV-2   Brouwer et al., 2020  
ALC_4259226 ARWRRTYYYDSSGYYPDAFDI 3-21 3       
C150 ARPTAVAAAGNYFYYYGMDV 3-74 6 CoV-2   Robbiani et al., 2020  
ALC_3663937 ARDSGVAAAGNY-YYYGMDV 3-7 6       
12E ARVGYYGDYAWGYYYYGMDV 1-18 6 CoV-1 CoV-1 WO2005060520 
ALC_3293962 ARH--YGDYVFGYYYYGMDV 4-39 6       
256 ARDGYGSGS-DYYYYYYMDV 3-30 6 CoV-1 CoV-1 Sui et al., 2006  
ALC_3985973 ARGGYGSGSYYNYYYYYMDV 1-69 6       
CV23 ARV-WGYCSGGSCYVDAFDI 1-3 3 CoV-2   Seydoux et al., 2020  
ALC_3664160 ARVGLGYCSGGSCY-SAFDI 4-34 3       
COV2-2146 ARRSYRSSWYYYYGMDV 3-48 6 CoV-2   Zost et al., 2020  
COV2-2263 ARRSYRSSWYYYYGMDV 3-48 6 CoV-2   
ALC_2822775 ARVGYSSSWYYYYGMDV 1-69 6       
0317-A9 ATATAMDGYYYYYGMDV 1-24 6 CoV-2   Chi et al., 2020  
ALC_2317864 AVNTAMD-YYYYYGMDV 3-21 6       
COV2-2844 ARAQGGN-YYYGMDV 3-30-3 6 CoV-1, CoV-2   Zost et al., 2020  
COV2-2564 ARAQGGN-YYYGMDV 3-30-3 6 CoV-1, CoV-2     
ALC_1782084 ARGQGGSQYYYGMDV 4-54 6       
COVA3-01 ARGPAATYYYYMDV 4-59 6 CoV-1, CoV-2   Brouwer et al., 2020  
COVA3-09 ARGPAATYYYYMDV 3-9 6 CoV-2   
ALC_1244470 ATGVAATYYYYMDV 4-61 6       
COV2-2832 ARGDGGYYSPFDY 3-66 4 CoV-2 CoV-2 Zost et al., 2020  
ALC_815774 ARSRGGYYSPFDY 3-30-3 4       
COV2-2919 ARTMATINAFDI 2-70 3 CoV-2 CoV-2 Zost et al., 2020  
ALC_482575 ARIMATINAFDI 2-70 3       
COV2-2178 ARVGSSSWYFDY 3-7 4 CoV-1, CoV-2   Zost et al., 2020  
ALC_482648 ARVPSSSWYFDY 3-11 4       
C109 AIQLWLRGGYDY 3-7 4 CoV-2   Robbiani et al., 2020  
ALC_481831 AVQLWLRGGFDY 4-59 4       
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BD-494 ARDLVVYGMDV 3-53 6 CoV-2 CoV-2 
Cao et al., 2020  BD-498 
ARDLVVYGMDV 3-53 6 CoV-2 CoV-2 
BD-505 ARDRVVYGMDV 3-53 6 CoV-2 CoV-2 
BD-507 ARDLVVYGMDV 3-53 6 CoV-2 CoV-2 
ALC_265226 ARVLTVYGMDV 3-33 6       
BD-604 ARDLGPYGMDV 3-53 6 CoV-2 CoV-2 Du et al., 2020  
ALC_269736 ARGAGPYGMDV 3-11 6       
C210 ARDLMAYGMDV 3-53 6 CoV-2 CoV-2 Robbiani et al., 2020  
ALC_261066 ARDSTAYGMDV 4-34 6       
CV10 ARGFDY 4-59 4 CoV-1, CoV-2   Seydoux et al., 2020  
ALC_7192 ARGFDY 1-2 4      
ALC_7213 ARGFDY 1-18 4      
ALC_7353 ARGFDY 5-51 4      
ALC_7448 ARGFDP 4-34 5       
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Supplementary Table 5. Details of the 463 convergent clonotypes that matched to samples in the 
Nielsen et al. data. 
 









CARRFDYW 3-23 4 6 5 1 
CARGFDYW 1-18 4 5 5 0 
CARGFDPW 4-34 5 5 5 0 
CARVFDYW 3-30 4 5 4 1 
CARVNSGSYLGAFDIW 3-30 3 5 4 1 
CARGFDYW 1-2 4 4 4 0 
CAREVLVYFDYW 3-33 4 4 4 0 
CARVLSYYGMDVW 3-23 6 4 4 0 
CARSSGYYYFDYW 3-30 4 4 4 0 
CARVVSYYYGMDVW 3-21 6 4 4 0 
CARVASYYYGMDVW 3-23 6 4 4 0 
CTRNDFWSGYYFDYW 3-7 4 4 4 0 
CARTYSGSYTDAFDIW 3-30 3 4 4 0 
CAREGVVGATTGLDYW 3-30 4 4 4 0 
CARDGVVTATTGLDYW 3-33 4 4 4 0 
CARDRIVGGTTGLDYW 3-33 4 4 4 0 
CTTVVYYYDSSGYSNDAFDIW 3-15 3 4 4 0 
CARGYSSGWYFDYW 3-30 4 4 3 1 
CARVPSSSWYFDYW 3-11 4 4 3 1 
CTTGGRLW 3-15 4 3 3 0 
CASGFDYW 1-69 4 3 3 0 
CARGVDPW 1-2 5 3 3 0 
CARDVGAQFDYW 3-30 4 3 3 0 
CARDLYTFGMDVW 3-53 6 3 3 0 
CAVYGYYYYGMDVW 3-30 6 3 3 0 
CAKVRGGYYYFDYW 3-30 4 3 3 0 
CAHRRSYYDAFDIW 2-5 3 3 3 0 
CTSNDFWSGYSDYW 3-49 4 3 3 0 
CARLGGTAWYFDLW 3-7 2 3 3 0 
CATDGIVGATGLDYW 3-33 4 3 3 0 
CAVPRGYSYGPFDYW 3-48 4 3 3 0 
CTRGDFWSGYWSDYW 3-49 4 3 3 0 
CSRPYSGSYYSYFDYW 3-30 4 3 3 0 
CARTYSGSYYSWFDPW 3-30-3 5 3 3 0 
CARVRSGSYYDAFDIW 3-30-3 3 3 3 0 
CARVRGGSYYGVFDYW 3-30 4 3 3 0 
CAKTVSGSYYSPFDYW 3-30 4 3 3 0 
CARVPGGSYYGPFDYW 3-30 4 3 3 0 
CARSNSGSYYHAFDIW 3-30-3 3 3 3 0 
CARVSSGSYFGAFDIW 3-30-3 3 3 3 0 
CATARAGSYYYGMDVW 3-23 6 3 3 0 
CAKVRGGSYRDAFDIW 3-30 3 3 3 0 
CASSGSGSYYSPFDYW 3-30 4 3 3 0 
CARTYSGSYYGAFDIW 3-23 3 3 3 0 
CAKTYSGSYYSSFDYW 3-30 4 3 3 0 
CARAYSGSYYYGMDVW 3-7 6 3 3 0 
CARAYSGSYWAAFDIW 3-30 3 3 3 0 
CARGYYDSSGYYNWFDPW 3-13 5 3 3 0 
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CARGRTVTTLYYYYGMDVW 4-39 6 3 3 0 
CARDSVLRYFDWTYYYYGMDVW 3-11 6 3 3 0 
CARVGYCSSTSCYSYYYYGMDVW 3-33 6 3 3 0 
CARGRPLDAFDIW 4-31 3 3 2 1 
CARDSTAYGMDVW 4-34 6 3 2 1 
CASVHSSSWFFDYW 3-7 4 3 2 1 
CARSGSYYGPFDYW 3-30 4 3 2 1 
CAKDSYSSSWYFDYW 3-30 4 3 2 1 
CARDSGPYYYGMDVW 3-30-3 6 3 2 1 
CARGFNYYDSSGFDYW 3-30 4 3 2 1 
CERDRSVCSSTSCYYYYGMDVW 3-30 6 3 2 1 
CARGRYYYDSSGYSYYYYGMDVW 1-69 6 3 2 1 
CATSGYW 1-24 4 2 2 0 
CTTWGGYW 3-15 4 2 2 0 
CAKGVDVW 3-23 6 2 2 0 
CAQGLDYW 4-59 4 2 2 0 
CAMGFDDW 4-59 4 2 2 0 
CAKSDGMDVW 3-9 6 2 2 0 
CAKDVGGNYGYW 3-23 4 2 2 0 
CAREYLVDLDYW 3-33 4 2 2 0 
CARTPGPYFDYW 3-30 4 2 2 0 
CARVVYDYFDYW 3-53 4 2 2 0 
CARGYRDYGDYW 3-33 4 2 2 0 
CARVLSYYGMDVW 4-34 6 2 2 0 
CARMTTVTTYDYW 2-70 4 2 2 0 
CARYSSSSDFDYW 1-69 4 2 2 0 
CARAVNFGWFDPW 1-18 5 2 2 0 
CVRDWGEYYFDYW 3-53 4 2 2 0 
CARGVWDLWYFDLW 4-34 2 2 2 0 
CARQQWLRGRFDYW 4-39 4 2 2 0 
CARETGSGSYPDYW 3-33 4 2 2 0 
CARVLGTYYYMDVW 3-30 6 2 2 0 
CARDLSYGDYNDYW 3-33 4 2 2 0 
CATLVDYYYYMDVW 3-9 6 2 2 0 
CARGGGYGHYFDYW 3-30-3 4 2 2 0 
CVGELLPYYGMDVW 3-33 6 2 2 0 
CAVQLWLRGGFDYW 4-59 4 2 2 0 
CAKVMAVAGTGDYW 3-30 4 2 2 0 
CARVLVPVYGMDVW 3-30 6 2 2 0 
CARVLSPLYGMDVW 3-33 6 2 2 0 
CARDYGDYGGLDYW 3-30 4 2 2 0 
CSKDIYGSGSYPDYW 3-9 4 2 2 0 
CVTPRGYSYGPFDYW 3-21 4 2 2 0 
CATGGRYYYYGMDVW 3-30 6 2 2 0 
CARDPVAVAGPFDYW 3-30 4 2 2 0 
CAREGVGATYYFDYW 3-30 4 2 2 0 
CARVQGGYYYGMDVW 3-30 6 2 2 0 
CAKGYSSSWYFFDYW 3-9 4 2 2 0 
CATPRVYSYGPFDYW 3-23 4 2 2 0 
CARTSGSYYSPFDYW 3-30-3 4 2 2 0 
CARDREAVAGPFDYW 3-30 4 2 2 0 
CAREGVGATYYFDYW 3-33 4 2 2 0 
CTRTDFWSGYYPDDW 3-49 4 2 2 0 
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CAKDVGYSSGLPDYW 3-9 4 2 2 0 
CTRYDFWSGYFSDYW 3-49 4 2 2 0 
CARGYSSYYWYFDLW 3-30 2 2 2 0 
CAREGIVGATGLDYW 3-30 4 2 2 0 
CATLRGGYYYGMDVW 3-9 6 2 2 0 
CASPRSGSYYGAFDIW 3-30-3 3 2 2 0 
CARTKSGSYWYYFDYW 3-30 4 2 2 0 
CARVRSGSYLSHFDYW 3-30 4 2 2 0 
CARVSSGSYYGWFDYW 3-30-3 4 2 2 0 
CARDRSGSYYHGMDVW 3-30 6 2 2 0 
CASSYSGSYLSAFDIW 3-30-3 3 2 2 0 
CVRAVAGTYYYGMDVW 3-30 6 2 2 0 
CSRSGSGSYYGWFDPW 3-30-3 5 2 2 0 
CATSPATVTTGWFDPW 1-24 5 2 2 0 
CARGSYGSYYYGMDVW 3-30 6 2 2 0 
CARVYSGSYFSPFDYW 3-30-3 4 2 2 0 
CARVYGGSYLGAFDIW 3-30 3 2 2 0 
CAKTNSGSYYYGMDVW 3-30 6 2 2 0 
CAKGPYGSGSYYVDYW 3-9 4 2 2 0 
CARGPRGYSYGYVDYW 3-21 4 2 2 0 
CAREGDYYYYYGMDVW 3-33 6 2 2 0 
CAREGVITGTTGLDYW 3-33 4 2 2 0 
CARVSGGSYYGNFDYW 3-30-3 4 2 2 0 
CARVRGGSYWGDFDYW 3-30 4 2 2 0 
CAREGQTTVTTGIDYW 3-33 4 2 2 0 
CATTSIVGATSWFDPW 1-24 5 2 2 0 
CARQEDYYDSSGFDYW 3-33 4 2 2 0 
CARTRSGSYLYYFDYW 3-30 4 2 2 0 
CARAYSGSYFNWFDPW 3-30-3 5 2 2 0 
CARDYSGSYLGLFDYW 3-30-3 4 2 2 0 
CARPYSGSYYWWFDPW 3-23 5 2 2 0 
CARDVAVAGDDAFDIW 3-33 3 2 2 0 
CARTRGGGYFDAFDIW 3-30-3 3 2 2 0 
CAKGVSGYYLDAFDIW 3-30 3 2 2 0 
CARTYSGSYRNWFDPW 3-33 5 2 2 0 
CARVPGGSYFGAFDIW 3-30-3 3 2 2 0 
CARVYGGSYIGYFDYW 3-30 4 2 2 0 
CARETLDSTSSDFDYW 3-30 4 2 2 0 
CARGSSGNYCYGMDVW 3-30 6 2 2 0 
CARRNSSGWYGDWFDPW 2-5 5 2 2 0 
CARATMIVVVVGAFDIW 4-31 3 2 2 0 
CSKDRPYDYVWGSLDYW 3-30 4 2 2 0 
CAKDWGYDYGDYGPDYW 3-30 4 2 2 0 
CATRYCSGGSCSLFDYW 4-4 4 2 2 0 
CARYDYYDSSGYYLDYW 1-69 4 2 2 0 
CTKADCSSTSCQNWFDPW 3-9 5 2 2 0 
CAKVGYSYGYPVYYFDYW 3-30 4 2 2 0 
CARVSYDSSGYYYYFDYW 3-13 4 2 2 0 
CARGGYSYGYYYYGMDVW 3-53 6 2 2 0 
CARSPITMIVVVNAFDIW 4-34 3 2 2 0 
CAREGTYCGGDCYSGLDYW 3-33 4 2 2 0 
CARTYYDILTGHNYGMDVW 2-70 6 2 2 0 
CARDSYSSSSYYYYYGMDVW 3-7 6 2 2 0 
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CARGRYSSSWYGVRNWFDPW 4-59 5 2 2 0 
CAKVSGPYCSGGSCYSFYFDYW 3-30 4 2 2 0 
CARGWPSSSWYEYYYYYGMDVW 4-34 6 2 2 0 
CAKVVGVYCSGGSCYGGYFDYW 3-30 4 2 2 0 
CTRGVPGYW 4-34 4 2 1 1 
CARSDGYNFDYW 4-59 4 2 1 1 
CARDGGVLFDYW 3-23 4 2 1 1 
CARDTSGWYLDYW 3-30-3 4 2 1 1 
CARVLSYYGMDVW 3-30-3 6 2 1 1 
CAGGSYYYGMDVW 3-33 6 2 1 1 
CARDRGYSYGSFDYW 3-33 4 2 1 1 
CARVLSGWYVGWFDPW 1-69 5 2 1 1 
CARVYSGSYYPAFDIW 3-21 3 2 1 1 
CAKGSWYSSSWYYFDYW 3-30 4 2 1 1 
CAKDRSGSYGYYGMDVW 3-30 6 2 1 1 
CARGGYSSSWYYYYGMDVW 3-13 6 2 1 1 
CARGFDYW 5-51 4 1 1 0 
CARGFVLW 4-59 4 1 1 0 
CAKGGDMDVW 3-30 6 1 1 0 
CAKVGGYFDYW 3-9 4 1 1 0 
CASWVNWFDPW 4-34 5 1 1 0 
CTSLSAPTDYW 3-74 4 1 1 0 
CPRGLEWELLNW 3-33 4 1 1 0 
CARESGSGLDYW 3-30-3 4 1 1 0 
CARWGGSGLDYW 3-30 4 1 1 0 
CARSVVSYFDYW 3-53 4 1 1 0 
CATSFYYYMDVW 3-21 6 1 1 0 
CARGGGDYVDYW 3-30-3 4 1 1 0 
CARDVGGYFDLW 3-30 2 1 1 0 
CARYHGSALDYW 3-30-3 4 1 1 0 
CAKEGIVLLDYW 3-30 4 1 1 0 
CARDSGSYLGWW 3-30 4 1 1 0 
CASLAGSGFDYW 3-30-3 4 1 1 0 
CARYSSGYYFDYW 3-21 4 1 1 0 
CATEGLLDAFDIW 3-30 3 1 1 0 
CARVLSGYGFDYW 3-30 4 1 1 0 
CARDPYGGGFDYW 3-30-3 4 1 1 0 
CARDGLSYGLDYW 3-30 4 1 1 0 
CARDSYSSGLDYW 3-7 4 1 1 0 
CAREGSGWTIDYW 3-30 4 1 1 0 
CAKVAAAGTTDYW 3-9 4 1 1 0 
CAREHGDYGFDYW 3-7 4 1 1 0 
CVGELPYYGMDVW 3-30 6 1 1 0 
CARNGGNNWFDPW 3-30-3 5 1 1 0 
CARDGTLEPLDYW 1-69 4 1 1 0 
CGRGYGDYWFDPW 3-53 5 1 1 0 
CARDLYDDAFDIW 3-66 3 1 1 0 
CARRYGVRPFDYW 2-70 4 1 1 0 
CARGAGPYGMDVW 3-11 6 1 1 0 
CVRARDGYNHFDYW 3-30-3 4 1 1 0 
CAKVSSYGYYFDYW 3-23 4 1 1 0 
CATSLLWFGELLYW 3-30 4 1 1 0 
CARGSSGYYYFDYW 3-30-3 4 1 1 0 
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CAKVYRSGNAFDIW 3-23 3 1 1 0 
CTGSTGYYYGMDVW 3-33 6 1 1 0 
CARSDGYNSYFDYW 3-30 4 1 1 0 
CARWLGGYYGMDVW 3-30-3 6 1 1 0 
CSRDYGDYGGMDVW 3-30 6 1 1 0 
CVREDYGDFGFDYW 3-30 4 1 1 0 
CARDYRFGELGDYW 3-33 4 1 1 0 
CASSSSPYYGMDVW 3-33 6 1 1 0 
CAVGLGYYYGMDVW 3-23 6 1 1 0 
CARDWAVGATTDYW 3-33 4 1 1 0 
CARRPVGVTPFDYW 5-51 4 1 1 0 
CAKMYGSGSYIDYW 3-9 4 1 1 0 
CARGGTLYDAFDIW 3-30-3 3 1 1 0 
CARSYSGYVPFDYW 2-70 4 1 1 0 
CARGWGGYYYFDYW 3-30 4 1 1 0 
CARTKTGYYYFDYW 3-30 4 1 1 0 
CARIMATINAFDIW 2-70 3 1 1 0 
CASTTYYYYYMDVW 1-18 6 1 1 0 
CARDVAVGDAFDSW 3-33 3 1 1 0 
CVRVVAATVSFDYW 2-70 4 1 1 0 
CAKLTYGDSPFDYW 3-9 4 1 1 0 
CASGSGSYYYFDYW 3-30 4 1 1 0 
CARYTGDYYGMDVW 5-51 6 1 1 0 
CARDGGLAAAFDYW 3-33 4 1 1 0 
CATELLWRYGMDVW 3-30 6 1 1 0 
CAKDPYGDLAFDYW 3-23 4 1 1 0 
CARDGGLVRGVDYW 3-33 4 1 1 0 
CTRDDFRSGYTNYW 3-49 4 1 1 0 
CARELSGWYGFDYW 3-33 4 1 1 0 
CARDRRLAEEFDYW 3-33 4 1 1 0 
CARDGTVTRTFDYW 3-33 4 1 1 0 
CTQDDFWSGYGHYW 3-49 4 1 1 0 
CGRDEYSSGWYFDYW 3-33 4 1 1 0 
CAKGRGYSYGYFDYW 3-30 4 1 1 0 
CTTGSGSYLGWFDPW 1-24 5 1 1 0 
CASGYSGSYWYFDYW 3-30 4 1 1 0 
CVLGSGSYYTPFDYW 3-30 4 1 1 0 
CARIYSSSWPSFDYW 2-70 4 1 1 0 
CARDSRGYSYGFDYW 3-33 4 1 1 0 
CARGGIAVADAFDIW 3-30 3 1 1 0 
CERAVVAAHNWFDPW 3-21 5 1 1 0 
CARGPRSSSDYFDYW 3-23 4 1 1 0 
CARDYLGYSYGSDYW 3-7 4 1 1 0 
CARVLVVNYYGMDVW 3-30 6 1 1 0 
CARDSIVSGWLFDYW 3-33 4 1 1 0 
CARQLTYYYYGMDVW 3-30 6 1 1 0 
CTRYDFWGGYYVDYW 3-49 4 1 1 0 
CARTSSGYYSKFDYW 3-30 4 1 1 0 
CARVGGIAVAGLDYW 3-30 4 1 1 0 
CARDLSGSYTYFDYW 3-30 4 1 1 0 
CATELLYYYYGMDVW 3-33 6 1 1 0 
CARDQRSSGWYVDYW 3-33 4 1 1 0 
CARTWAAAGLGADYW 2-70 4 1 1 0 
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CARSRGGYYSPFDYW 3-30-3 4 1 1 0 
CARESVAALDAFDIW 3-30 3 1 1 0 
CARARGGSYSYFDYW 3-30 4 1 1 0 
CARGYGDYVPNFDYW 4-34 4 1 1 0 
CAREGVTATVYFDYW 3-74 4 1 1 0 
CARESIVVVPAADYW 3-74 4 1 1 0 
CSRNYYDSSDAFDIW 3-30 3 1 1 0 
CARTLVLSYYGMDVW 3-33 6 1 1 0 
CARVLVLYYYGMDVW 3-30-3 6 1 1 0 
CATNDYYYYYYMDVW 3-33 6 1 1 0 
CVRDMSGSYYGPFDYW 3-30 4 1 1 0 
CATVHSGSYLGYFDYW 3-30 4 1 1 0 
CASAGSGSYRGWFDPW 3-30 5 1 1 0 
CPRGYSGSYFSAFDIW 3-30 3 1 1 0 
CARVYSGSYYSHFDYW 3-30 4 1 1 0 
CARTWSGSYLSWFDPW 3-30-3 5 1 1 0 
CVRSYSGSYFSWFDPW 3-30 5 1 1 0 
CTRYYSGSYYYGMDVW 3-30-3 6 1 1 0 
CATTRGGSYYGAFDIW 3-30 3 1 1 0 
CVRGVGGGYYYGMDVW 3-30-3 6 1 1 0 
CATVPIFGVVSWFDPW 1-24 5 1 1 0 
CERETGDSSSSYFDYW 3-30 4 1 1 0 
CARVVGANYYYGMDVW 3-30 6 1 1 0 
CASVSSGYYYGAFDYW 3-30 4 1 1 0 
CARSVYGDYYYYMDVW 4-59 6 1 1 0 
CARTYSGSYYTPFDYW 3-30-3 4 1 1 0 
CSRVSVVYYYYGMDVW 3-48 6 1 1 0 
CARESIVVVHDAFDIW 3-30 3 1 1 0 
CARTYYYDSSGYWDYW 3-30 4 1 1 0 
CATTYSGSYKGYFDYW 3-30 4 1 1 0 
CATSPAALRSNWFDPW 1-24 5 1 1 0 
CAKDPVGATYDALDIW 3-23 3 1 1 0 
CARTYSGIYLAPFDYW 3-30 4 1 1 0 
CARARGGYYSRPFDYW 3-30 4 1 1 0 
CARSGSGSYFAYFDYW 3-30 4 1 1 0 
CARGWSGSYRTYFDYW 3-30-3 4 1 1 0 
CATGPVVVAATWFDPW 1-24 5 1 1 0 
CSRPGSGSYLSWFDPW 3-30 5 1 1 0 
CATSAVAGTWGWFDPW 1-24 5 1 1 0 
CATSPAIAVAGWFDPW 1-24 5 1 1 0 
CARHWDNFWSGYYHYW 5-51 4 1 1 0 
CATGPVAGTSNWFDPW 1-24 5 1 1 0 
CARVLSGSYWGWFDPW 3-30 5 1 1 0 
CPRALWGNYYYGMDVW 3-30-3 6 1 1 0 
CARSRGGSYSNAFDIW 3-30 3 1 1 0 
CARTSRGSYYDAFDIW 3-30 3 1 1 0 
CARGSSGTYYYGMDGW 3-30 6 1 1 0 
CARVSYDSLTGYYDYW 3-13 4 1 1 0 
CARTNIAAAGTAVDYW 2-70 4 1 1 0 
CARTSGGSYRGWFDPW 3-30-3 5 1 1 0 
CASSNSGSYWGAFDIW 3-30 3 1 1 0 
CARDVGSGWYGYFDYW 3-33 4 1 1 0 
CATGPTGSYYDYFDYW 3-30 4 1 1 0 
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CASPYSGSYYSHFDYW 3-30 4 1 1 0 
CARSSRGSYLNWFDPW 3-30 5 1 1 0 
CARELIAAAGYYFDYW 3-33 4 1 1 0 
CARSRSGSYSSAFDYW 3-30 4 1 1 0 
CATSEVAGPLNWFDPW 1-24 5 1 1 0 
CPRGYSGSYYEYFQHW 3-30 1 1 1 0 
CARVGGGSYFNWFDPW 3-30-3 5 1 1 0 
CASPRGGSYYGEFDYW 3-30-3 4 1 1 0 
CARDLSGSYYYGLDVW 3-30-3 6 1 1 0 
CARDSSGSYYGPNDYW 3-30-3 4 1 1 0 
CARVYSGSYRGFFDYW 3-33 4 1 1 0 
CARVTYGNYYYGMDVW 3-30 6 1 1 0 
CATGPPFGVVSWFDPW 1-24 5 1 1 0 
CARVHSGSYYGDFDYW 3-30-3 4 1 1 0 
CARPYSGSYWSYVDYW 3-30-3 4 1 1 0 
CARSYSGSYYHAFDIW 3-33 3 1 1 0 
CAKTLSGSYYSPFYYW 3-30 4 1 1 0 
CARPYSGSYFAQFDYW 3-30-3 4 1 1 0 
CANPYSGSYRDAFDIW 3-30 3 1 1 0 
CARAYSGSYYYGMDVW 3-53 6 1 1 0 
CARGRGGGYHDAFDIW 3-30 3 1 1 0 
CVTTTIFGVKGWFDPW 1-24 5 1 1 0 
CARGTRGSYYYGMDVW 3-30-3 6 1 1 0 
CARDLVGAAYYGMDVW 3-33 6 1 1 0 
CARVTGANYYYGMDVW 3-30 6 1 1 0 
CARSKGGGYYPPFDYW 3-30 4 1 1 0 
CARTYSGSYYSYFDDW 3-30-3 4 1 1 0 
CARVYSGSYRGHFDYW 3-30 4 1 1 0 
CAKGKMGGYYYGMDVW 3-30 6 1 1 0 
CARTNGGGYYYGMDVW 3-33 6 1 1 0 
CASASGGNYYYGMDVW 3-30-3 6 1 1 0 
CARGWSSGWSYYFDYW 3-53 4 1 1 0 
CARGLRFLEWYYFDYW 4-34 4 1 1 0 
CATASVFGVANWFDPW 1-24 5 1 1 0 
CARSRSGSYTSWFDPW 3-30-3 5 1 1 0 
CARVSSGSYRSAFDIW 3-30-3 3 1 1 0 
CARGFGGSYYYGMDVW 3-53 6 1 1 0 
CARSLGGSYYVAFDIW 3-30 3 1 1 0 
CARTSGSYYYYFGMDVW 4-59 6 1 1 0 
CARDTYYDILTGYYLYW 3-21 4 1 1 0 
CARGVDLYYYYYGMDVW 4-34 6 1 1 0 
CARSGYYYDSSGYSDYW 3-21 4 1 1 0 
CARRYYGYYYYYGMDVW 4-39 6 1 1 0 
CATPRYYYDSSGTFDYW 3-23 4 1 1 0 
CAKFADYYDSSGYYDYW 3-9 4 1 1 0 
CARDTNYDILTGYYSYW 3-21 4 1 1 0 
CAREGQIAVAGTGLDYW 3-33 4 1 1 0 
CATSPPMAAAGNWFDPW 1-24 5 1 1 0 
CARDVDASGYYYGMDVW 3-7 6 1 1 0 
CATGGGYYYYYYGMDVW 3-30 6 1 1 0 
CARDLAVAGTSEYFQHW 3-33 1 1 1 0 
CAREVIAVAGSNWFDPW 3-30 5 1 1 0 
CARESLYGDYGGAFDIW 3-33 3 1 1 0 
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CARAGGSGSYYGWFDPW 3-30-3 5 1 1 0 
CARVGRTIFGVVTNFDYW 4-31 4 1 1 0 
CARRGYYDSSGYYYFDYW 5-51 4 1 1 0 
CAREYYYDSSGYYPRDYW 1-18 4 1 1 0 
CATSPSIAAAGNNWFDPW 1-24 5 1 1 0 
CSKDYDSSGYYSDAFDIW 3-23 3 1 1 0 
CATGPYCGGDCYGAFDIW 1-69 3 1 1 0 
CARSNYDFWSGYLPFDYW 3-7 4 1 1 0 
CVRNYDILTGYSDAFDIW 3-53 3 1 1 0 
CAREGYSSSWSLYYFDYW 3-33 4 1 1 0 
CARDVFYDFWSGYYFDYW 1-3 4 1 1 0 
CAKNGYSYGYGGYYFDYW 3-30 4 1 1 0 
CAKDSNGSGSYHDAFDIW 3-23 3 1 1 0 
CARASYDSSGYYAYFDYW 3-13 4 1 1 0 
CAREVDIVVVPAAPFDYW 1-46 4 1 1 0 
CASGAVAGYYYYYGMDVW 3-21 6 1 1 0 
CARDDYDYVWGSYSTDYW 3-30 4 1 1 0 
CAKDRYYYDSSGYYYFDYW 3-23 4 1 1 0 
CARSYYDILTGYLAAFDIW 2-5 3 1 1 0 
CARIPYDILTGSLYGMDVW 2-70 6 1 1 0 
CATIAAAGTHYYYYGMDVW 3-48 6 1 1 0 
CASDYYDSSGYYNDWFDPW 3-30 5 1 1 0 
CTTDRLGATYYYYYGMDVW 3-15 6 1 1 0 
CSRDYYDSSGYYNNWFDPC 3-30-3 5 1 1 0 
CARTHYGGNYYYYYGMDVW 3-13 6 1 1 0 
CARYCSSTSCYTDDAFDIW 4-39 3 1 1 0 
CARGGYSYGWSYYYGMDVW 3-53 6 1 1 0 
CARVKRITIFGVVTHFDYW 4-59 4 1 1 0 
CARGYYDILTGYYREFDYW 2-70 4 1 1 0 
CATNFAYCGGDCYSRFDYW 1-24 4 1 1 0 
CARGRGIQLWNYYYGMDVW 4-31 6 1 1 0 
CATTSPYCSSTSCPRWFDPW 1-24 5 1 1 0 
CSRGRYSSSWYGVAEYFQHW 4-34 1 1 1 0 
CATDLYCSGGSCYSFGMDVW 3-23 6 1 1 0 
CATLAAAGPEWYYYYGMDVW 3-21 6 1 1 0 
CVRRRYSSSWPDYYYGMDVW 5-51 6 1 1 0 
CARSYCSSTSCYGYYYMDVW 4-59 6 1 1 0 
CARGGLAVAGTYYYYGVDVW 3-21 6 1 1 0 
CARDPDYYDSSGYYVGFDYW 3-30-3 4 1 1 0 
CARLTTVTTNYYYYYGMDVW 1-69 6 1 1 0 
CARGRYSSSWYGVRNWFDPW 4-31 5 1 1 0 
CARVVGGYCSSTSCYYFDYW 1-18 4 1 1 0 
CATVGVYCTNGVCSNWFDPW 1-24 5 1 1 0 
CARDLTYYYDSSGWGHFDYW 3-30 4 1 1 0 
CAREVYDSSGYYYEDWFDPW 3-74 5 1 1 0 
CARGYWNYVRYYYYYGMDVW 1-69 6 1 1 0 
CARGTTVTTLFYYYYGMDVW 4-39 6 1 1 0 
CVRGIVVVPAAHYYYYGMDVW 1-18 6 1 1 0 
CARHPDIAVAGYYYYYGMDVW 4-59 6 1 1 0 
CARWGWGSGSPNYYYYYMDVW 1-69 6 1 1 0 
CARSGAGYSYGYAYYYYMDVW 1-69 6 1 1 0 
CARGRWFGELLSYYYYGMDVW 4-4 6 1 1 0 
CARVGLGYCSSTSCYTAFDIW 4-39 3 1 1 0 
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CARESGGYCSGGSCPNWFDPW 1-46 5 1 1 0 
CARGRWFGELLSYYYYGMDVW 4-31 6 1 1 0 
CARVGVLRYFDWQAYYYGMDVW 4-39 6 1 1 0 
CARGGVYYYDSSGYYLDAFDIW 1-2 3 1 1 0 
CARGRIAAAGLCNYYYYGMDVW 4-34 6 1 1 0 
CVRGRRITIFGVVIDSFGMDVW 4-34 6 1 1 0 
CARVTVLRYFDWSYYYYGMDVW 4-31 6 1 1 0 
CARDSRFWEWLLYSYYYYMDVW 3-21 6 1 1 0 
CARVTYYYDSSGYPFYWYFDLW 3-13 2 1 1 0 
CARNGLYYYDSSGYYLDAFDIW 3-23 3 1 1 0 
CARTGVLRYFDWSYYYYGMDVW 4-61 6 1 1 0 
CARVPLLRYFDWTYYYYGMDVW 4-59 6 1 1 0 
CARVGVLRYFDWLLHYYGMDVW 4-39 6 1 1 0 
CAKVVGPYCSGGSCYSGQLDYW 3-30 4 1 1 0 
CARGGYGSGSYYNYYYYYMDVW 1-69 6 1 1 0 
CARDSVLRYFDWLPYYYGMDVW 4-61 6 1 1 0 
CARDSYSSSWLGSYYYYGMDVW 3-7 6 1 1 0 
CARDRYCSSTSCYRDYYYGMDVW 1-18 6 1 1 0 
CARGWIVVVPAATYYYYYGMDVW 4-34 6 1 1 0 
CARDRYCSGGSCYVYYYYGMDVW 1-18 6 1 1 0 
CARVSYSSSWYWGDYYYYGMDVW 1-69 6 1 1 0 
CARDTYCSGGSCYYYYYYGMDVW 3-7 6 1 1 0 
CARVWGAGYSSGWYYYYYYMDVW 4-59 6 1 1 0 
CARDVSSSWYSSGWYYYYYMDVW 3-7 6 1 1 0 
CAKMGGGPYCSGGSCYSNYFDYW 3-30 4 1 1 0 
CARGYTMVRGVIPRYYYYYMDVW 3-13 6 1 1 0 
CARVGYCSSTSCYVPYYYYGMDVW 1-2 6 1 1 0 
CARDVDIVVVPAATNYYYYGMDVW 3-21 6 1 1 0 
CARDVTYYDILTGYYPQYYYYGMDVW 3-33 6 1 1 0 
CARHLYYYDSSGYYYPPYYYYGMDVW 3-30 6 1 1 0 
CARYQYYYDSSGYYYPTPYYYGMDVW 3-30-3 6 1 1 0 
CARVGGGMDVW 1-46 6 1 0 1 
CVKERQWLAYFDYW 3-30 4 1 0 1 
CARGRYYDSSGLDYW 3-74 4 1 0 1 
CARELVAGYYGMDVW 3-30 6 1 0 1 
CARDSYSSSWYFDYW 3-30 4 1 0 1 
CARGRGSYYGWFDPW 3-30 5 1 0 1 
CARGYSSGYYYYFDYW 3-13 4 1 0 1 
CARDPSSSWYIYFDYW 3-30 4 1 0 1 
CASDPYYYDSSGLLDYW 3-21 4 1 0 1 
CARSYDILTGYLYFDYW 3-30 4 1 0 1 
CARVRYYDSSGYYSPFDYW 1-69 4 1 0 1 
CARDLAVAATYYYYYGMDVW 3-7 6 1 0 1 
CARDSGVAAAGNYYYYGMDVW 3-7 6 1 0 1 
 
 
 
